$186 Million is the total value of SABBY MANAGEMENT, LLC's 93 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 46.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | ISHARES TRput | $23,881,000 | +8584.0% | 1,578 | -38.3% | 12.87% | +3619.4% | |
| Sell | SPDR S&P BIOTECHput | $3,866,000 | +3446.8% | 507 | -40.6% | 2.08% | +1420.4% | |
| Sell | AMARIN CORPput | $3,482,000 | -28.3% | 2,297 | -8.3% | 1.88% | -69.3% | |
| ODT | Sell | ODONATE THERAPEUTICS INC | $2,417,000 | -50.5% | 92,854 | -30.2% | 1.30% | -78.8% |
| CJJD | Sell | CHINA JO-JO DRUGSTORES INC | $1,590,000 | -20.9% | 1,325,299 | -27.5% | 0.86% | -66.1% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $1,384,000 | -28.5% | 477,351 | -3.4% | 0.75% | -69.4% |
| INNT | Sell | INNOVATE BIOPHARMACEUTICLS INC | $1,336,000 | -13.8% | 1,248,814 | -6.5% | 0.72% | -63.1% |
| Sell | CORMEDIX INCput | $1,235,000 | -52.0% | 1,936 | -58.2% | 0.67% | -79.4% | |
| PAVMZ | Sell | PAVMED INC*w | $949,000 | -30.9% | 2,964,629 | -9.3% | 0.51% | -70.4% |
| PULM | Sell | PULMATRIX INC | $866,000 | -12.0% | 1,058,682 | -0.8% | 0.47% | -62.2% |
| Sell | DIFFUSION PHARMACEUTICALS INC | $865,000 | -35.3% | 467,819 | -0.2% | 0.47% | -72.3% | |
| Sell | CEL SCI CORPput | $764,000 | +8.7% | 855 | -38.6% | 0.41% | -53.4% | |
| ORMP | Sell | ORAMED PHARMACEUTICALS INC | $593,000 | -53.4% | 185,800 | -47.6% | 0.32% | -80.0% |
| SOLO | Sell | ELECTRAMECCANICA VEHS CORP | $587,000 | -48.1% | 288,408 | -36.3% | 0.32% | -77.8% |
| SHIP | Sell | SEANERGY MARITIME HOLDINGS CORP | $583,000 | -43.5% | 1,210,099 | -27.5% | 0.31% | -75.8% |
| AMRN | Sell | AMARIN CORPadr | $470,000 | -22.8% | 30,990 | -1.4% | 0.25% | -67.0% |
| GNPX | Sell | GENPREX INC | $462,000 | -42.1% | 577,323 | -10.3% | 0.25% | -75.2% |
| SYN | Sell | SYNTHETIC BIOLOGICS INC | $379,000 | -23.7% | 835,459 | -7.6% | 0.20% | -67.4% |
| AVCO | Sell | AVALON GLOBOCARE CORP | $369,000 | -58.5% | 197,119 | -42.3% | 0.20% | -82.2% |
| ALRN | Sell | AILERON THERAPEUTICS INC | $368,000 | -49.5% | 549,900 | -45.6% | 0.20% | -78.4% |
| OGEN | Sell | ORAGENICS INC | $334,000 | -45.9% | 618,822 | -50.9% | 0.18% | -76.8% |
| CYTR | Sell | CYTRX CORP | $237,000 | -35.2% | 729,450 | -31.2% | 0.13% | -72.2% |
| BLIN | Sell | BRIDGELINE DIGITAL INC COM | $210,000 | -22.2% | 110,000 | -0.4% | 0.11% | -66.7% |
| VBLT | Sell | VASCULAR BIOGENICS LTD | $162,000 | -47.9% | 119,681 | -50.0% | 0.09% | -77.7% |
| MDGSW | Sell | MEDIGUS LTD*w | $101,000 | -53.7% | 1,008,444 | -2.2% | 0.05% | -80.3% |
| EYEN | Sell | EYENOVIA INC | $66,000 | -69.0% | 17,900 | -63.8% | 0.04% | -86.6% |
| TMDI | Sell | TITAN MEDICAL INC | $44,000 | -83.4% | 41,085 | -63.4% | 0.02% | -92.8% |
| Sell | SESEN BIO INCput | $43,000 | -38.6% | 365 | -34.9% | 0.02% | -73.9% | |
| Sell | ALTIMMUNE INC COMput | $26,000 | -69.4% | 134 | -42.5% | 0.01% | -86.9% | |
| ONTXW | Sell | ONCONOVA THERAPEUTICS INC*w | $13,000 | -88.7% | 631,812 | -1.6% | 0.01% | -95.2% |
| Sell | TITAN PHARMACEUTICALS INCput | $3,000 | -98.6% | 106 | -93.4% | 0.00% | -99.2% | |
| BNTCW | Sell | BENITEC BIOPHARMA LTD*w | $1,000 | 0.0% | 51,449 | -9.7% | 0.00% | 0.0% |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -134,192 | -100.0% | -0.00% | – |
| FCEL | Exit | FUELCELL ENERGY INC | $0 | – | -17,640 | -100.0% | -0.00% | – |
| SINT | Exit | SINTX TECHNOLOGIES INC | $0 | – | -84,655 | -100.0% | -0.01% | – |
| KTOV | Exit | KITOV PHARMA LTDads | $0 | – | -14,500 | -100.0% | -0.02% | – |
| SGLBW | Exit | SIGMA LABS INC*w | $0 | – | -65,033 | -100.0% | -0.03% | – |
| SPHS | Exit | SOPHIRIS BIO INC | $0 | – | -52,685 | -100.0% | -0.06% | – |
| Exit | APPLIED DNA SCIENCES INCput | $0 | – | -390 | -100.0% | -0.10% | – | |
| APDNW | Exit | APPLIED DNA SCIENCES INC*w | $0 | – | -21,504 | -100.0% | -0.11% | – |
| CALA | Exit | CALITHERA BIOSCIENCES INC | $0 | – | -28,806 | -100.0% | -0.14% | – |
| APOP | Exit | CELLECT BIOTECHNOLOGY LTDads | $0 | – | -243,563 | -100.0% | -0.16% | – |
| UMRX | Exit | UNUM THERAPEUTICS INC | $0 | – | -50,922 | -100.0% | -0.17% | – |
| Exit | AETERNA ZENTARIS INCput | $0 | – | -501 | -100.0% | -0.17% | – | |
| ISR | Exit | ISORAY INC | $0 | – | -370,612 | -100.0% | -0.19% | – |
| AVEO | Exit | AVEO PHARMACEUTICALS INC COM | $0 | – | -281,112 | -100.0% | -0.24% | – |
| OPGN | Exit | OPGEN INC | $0 | – | -519,341 | -100.0% | -0.26% | – |
| RMTI | Exit | ROCKWELL MED INC | $0 | – | -72,059 | -100.0% | -0.27% | – |
| CODX | Exit | CO DIAGNOSTICS INC | $0 | – | -279,595 | -100.0% | -0.28% | – |
| HEB | Exit | HEMISPHERX BIOPHARMA INC | $0 | – | -60,858 | -100.0% | -0.34% | – |
| SCON | Exit | SUPERCONDUCTOR TECHNOLOGIES | $0 | – | -467,900 | -100.0% | -0.48% | – |
| EMAN | Exit | EMAGIN CORP | $0 | – | -861,903 | -100.0% | -0.49% | – |
| SLS | Exit | SELLAS LIFE SCIENCES GROUP INC | $0 | – | -3,926,022 | -100.0% | -0.56% | – |
| STOK | Exit | STOKE THERAPEUTICS INC | $0 | – | -16,202 | -100.0% | -0.60% | – |
| CANF | Exit | CAN FITE BIOPHARMA LTD | $0 | – | -211,896 | -100.0% | -0.77% | – |
| BCLI | Exit | BRAINSTORM CELL THERAPEUTICS INC | $0 | – | -158,152 | -100.0% | -0.79% | – |
| Exit | WAVE LIFE SCIENCES LTDcall | $0 | – | -552 | -100.0% | -1.81% | – | |
| SHIPW | Exit | SEANERGY MARITIME HOLDINGS CORP*w | $0 | – | -965,000 | -100.0% | -1.94% | – |
| AMPE | Exit | AMPIO PHARMACEUTICALS INC | $0 | – | -5,265,265 | -100.0% | -2.57% | – |
| Exit | BIOGEN INCcall | $0 | – | -410 | -100.0% | -12.06% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.